Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome
Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc.
Dana-Farber Cancer Institute
Advanced Accelerator Applications
Taproot Health
University Medical Center Groningen
Roswell Park Cancer Institute
Radio Isotope Therapy of America
H. Lee Moffitt Cancer Center and Research Institute
Ipsen
University of Iowa
Novartis
University of Iowa
H. Lee Moffitt Cancer Center and Research Institute
Eli Lilly and Company
Novartis
Arbutus Biopharma Corporation
Dana-Farber Cancer Institute
Mateon Therapeutics
Novartis
Dana-Farber Cancer Institute
Columbia University
Vanderbilt-Ingram Cancer Center
Dana-Farber Cancer Institute
H. Lee Moffitt Cancer Center and Research Institute
Molecular Insight Pharmaceuticals, Inc.
Cylene Pharmaceuticals